Skip to content

Medical-device intelligence

ODW: Cytochrome P450 2c9 (Cyp450 2c9) Drug Metabolizing Enzyme Genotyping System

FDA product code ODW: Cytochrome P450 2c9 (Cyp450 2c9) Drug Metabolizing Enzyme Genotyping System. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
ODW
FDA device name
Cytochrome P450 2c9 (Cyp450 2c9) Drug Metabolizing Enzyme Genotyping System
Device class
2
Regulation number
862.3360
Medical specialty
Clinical Toxicology
Review panel
TX

FDA definition

An in vitro diagnostic assay for use in genotyping Cytochrome P450 2C9 (CYP450 2C9) alleles. Information about the CYP2C9 genotype may be used as an aid to clinicians in determining therapeutic strategy for medications that are metabolized by the CYP2C9 gene product.
Explore clinical toxicology records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

6 clearance records and 1 recall records in the covered releases, across 6 source company names and 1 product codes. Dated history runs from Sep 17, 2007 to May 24, 2019.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

7 matching records
Device / recordCompany in FDA recordSourceSource date
TruDiagnosis SystemK183530 · ODWAkonni Biosystems, Inc.510(k)May 24, 2019FDA decision date
eSensor Warfarin Sensitivity Saliva TestK152612 · ODWGenmark Diagnostics, Incorporated510(k)May 26, 2016FDA decision date
EQ-PRC LC WARFARIN GENOTYPING KITK073071 · ODWTrimgen Corporation510(k)Feb 6, 2009FDA decision date
ESENSOR WARFARIN SENSITIVITY AND XT-8 INSTRUMENTK073720 · ODWOsmetech Molecular Diagnostics510(k)Jul 17, 2008FDA decision date
Warfarin Metabolism Nucleic Acid Test Cartridge; Part Number: 20-006-002; an in vitro diagnostic drug metabolizing enzyme genotyping system; Nano…Z-1383-2008 · ODWNanosphere, Inc.RecallMar 31, 2008FDA classification date
INFINITI 2C9 & VKORC1 MULTIPLEX ASSAY FOR WARFARINK073014 · ODWAutogenomics, Incorporated510(k)Jan 23, 2008FDA decision date
VERIGENE SYSTEM, VERIGENE WARFARIN METABOLISM NUCLEIC ACID TESTK070804 · ODWNanosphere, Inc.510(k)Sep 17, 2007FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 21, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗